Nightmares
Conditions
Brief summary
The purpose of this study is to obtain preliminary data of the efficacy of Exposure, Relaxation, and Rescripting Therapy for nightmares among active duty military personnel.
Detailed description
This will be a pilot randomized controlled trial to compare the effects of Exposure, Relaxation, and Rescripting Therapy for military populations (ERRT-M) among active duty service members. Participants will be randomized to 5 sessions of ERRT-M (n = 20 ) or to a 5-week waitlist control group (WL; n = 20). Participants will complete all interviews and self-report measures 1 weeks following treatment or the WL condition and 1 month after completing treatment.
Interventions
BEHAVIORALERRT-M for Nightmares
Exposure, Relaxation, and Rescripting Therapy Military version (ERRT-M) - Five 60-90 minute sessions administered once weekly. ERRT-M includes psychoeducation, sleep habit modification, relaxation training, written exposure to and rescription of nightmare content and imagery rehearsal of rescripted dream content.
Sponsors
American Academy of Sleep Medicine
The University of Texas Health Science Center at San Antonio
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Active duty military stationed at Fort Hood as assessed by self-report. * Able to speak and read English. * History of a traumatic event. * Nightmare Disorder * Stable on psychotropic and/or hypnotic medications and/or interventions for sleep (e.g., Continuous Positive Air Pressure for sleep apnea) administered by other providers for at least one month assessed by self-report and review of medical record. * Willingness to refrain from beginning new behavioral health or medication treatment for issues pertaining to sleep, PTSD, or nightmares during participation in the study. * Indication that the SM plans to be in the area for the 5 months following the first assessment
Exclusion criteria
* Current suicide or homicide risk meriting crisis intervention. * Severe brain damage, assessed by the inability to comprehend baseline questionnaires. * Pregnancy at baseline. * Serious mental health diagnosis such as bipolar disorder or psychosis, assessed with the pre-treatment health interview and review of medical record. * Currently taking propranolol. * Currently engaged in evidence-based treatment for PTSD (i.e., Prolonged Exposure Therapy or Cognitive Processing Therapy) or Insomnia (i.e., Cognitive Behavioral Therapy for Insomnia).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of nightmares reported on the Nightmare Log | Change from baseline to 2-week posttreatment |
Secondary
| Measure | Time frame |
|---|---|
| Total score on the Insomnia Severity Index (ISI) | Change from baseline to 2-week posttreatment |
| Total score on the Clinician Administered PTSD Scale (CAPS-5) | Change from baseline to 2-week posttreatment |
| Total score on the PTSD Checklist -DSM-5 (PCL-5) | Change from baseline to 2-week posttreatment |
| Total score on the Patient Health Questionnaire (PHQ-9) | Change from baseline to 2-week posttreatment |
Countries
United States
Outcome results
None listed